DiaMedica Therapeutics (DMAC) Other Non Operating Income (2018 - 2026)

DiaMedica Therapeutics has reported Other Non Operating Income for 9 years, with the latest figure at $447000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 0.9% year-over-year to $447000.0; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 22.79% YoY), and the FY2025 full-year result was $1.7 million, down 26.82% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $447000.0, down from $1.7 million in the prior quarter.
• The five-year high for Other Non Operating Income was $2.3 million in Q4 2024, with the low at -$21000.0 in Q3 2025.
• Historically, Other Non Operating Income has averaged $453823.5 across 5 years, with a median of $256000.0 in 2023.
• Annual changes were most pronounced in 2022 — Other Non Operating Income surged 3171.43% — and 2025, when it plunged 950.0%.
• DiaMedica Therapeutics' Other Non Operating Income stood at $229000.0 in 2022, then soared by 209.61% to $709000.0 in 2023, then surged by 222.43% to $2.3 million in 2024, then retreated by 26.51% to $1.7 million in 2025, then tumbled by 73.39% to $447000.0 in 2026.
• The last three Other Non Operating Income figures came in at $447000.0 (Q1 2026), $1.7 million (Q4 2025), and -$21000.0 (Q3 2025), per Business Quant data.